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Purpose: In contrast to proximal deep vein thrombosis (DVT), the treatment of isolated calf vein thrombosis (ICVT) remains 
controversial. This study aimed to investigate early treatment outcomes of ICVT after total knee arthroplasty (TKA). 
Methods: Medical records of 313 patients who underwent TKA from October 2007 to December 2009 were retrospectively 
reviewed. A DVT-computed tomography (CT) was performed 7 days after surgery. ICVT was identified in 76 limbs of 73 
patients. Of them, follow-up DVT-CT was available in 39 limbs of 37 patients. The patients with ICVTs were categorized into 
two groups: oral anticoagulation group (group I, 17 patients with 18 limbs) and conservative treatment group (group II, 20 
patients with 21 limbs). Group I received an oral vitamin K antagonist for 3 to 6 months following low molecular weight 
heparin. Change of thrombus extent and development of pulmonary embolism (PE) was assessed in follow-up DVT-CT. 
Results: Mean age was 68 years and 95% were female. Of 39 limbs with ICVT, 16 (41%) involved major lower leg veins 
(posterior tibial vein or peroneal vein), 13 (33%) involved muscular veins (soleal vein or gastrocnemius vein) and 10 (26%) in-
volved both. During 1 to 6 months, follow-up DVT-CT revealed complete thrombus resolution in all limbs and there was no 
proximal propagation of thrombus or PE in both groups. Conclusion: There is no evidence of DVT propagation or newly de-
veloped PE in the conservative treatment group. This result suggests that anticoagulation therapy for ICVT patients without 
PE after TKA may not be mandatory.
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INTRODUCTION
The prevalence of isolated calf vein thrombosis (ICVT) 
is 5 to 12% in symptomatic patients [1] and asymptomatic 
ICVT may occurin 15% of patients after total hip and total 
knee arthroplasty (TKA) [2]. However, treatment of ICVT 
is still controversial.
Generally, ICVT is not considered to be a source of fatal 
pulmonary embolism (PE) because the severity of PE de-
pends on the size of the emboli or cardiopulmonary func-
tion [3]. However, some authors who recommend anti-
coagulation therapy are concerned that untreated ICVT 
may extend to proximal deep veins, which is more likely to 
result in PE [4].Outcome of isolated calf vein thrombosis
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Table 1. Risk factors for venous thromboembolism (VTE) in 37 
patients with isolated calf vein thrombosis (ICVT)
Risk factor
Oral 
anticoagulation 
(n = 17)
Conservative 
treatment 
(n = 20)
Total 
(n = 37)
 Prior VTE 2
a) (12) 1
b) (5)   3 (8)
 Body mass index 8 (47) 6 (30) 14 (38)
   ＞  25 kg/m
2
 Estrogen therapy 0 (0) 0 (0)   0 (0)
 Smoking 1 (6) 1 (5)   2 (5)
 Malignancy 0 (0) 1
c) (5)   1 (3)
Values are presented as no. of patients (%).
a)One patient with May-Thurner syndrome previously underwent 
catheter-directed thrombolytic therapy with left iliac vein stenting 
and the other had ICVT after previous contralateral total knee 
arthroplasty (TKA). 
b)ICVT after previous contralateral TKA. 
c)Thy-
roid cancer.
This study aimed to investigate short-term treatment 
outcomes (e.g., proximal thrombus propagation and in-
cidence of PE) in patients with ICVT after TKA according 
to whether or not they were treated with anticoagulation 
therapies.
METHODS
Between October 2007 and December 2009, 313 TKAs 
were performed in Kyungpook National University 
Hospital. During the perioperative period, prophylactic 
anticoagulation was not administered and only a com-
pression stocking was applied. On postoperative day 7, a 
deep vein thrombosis-computed tomography (DVT-CT) 
designed in our hospital was performed on all patients for 
venous thromboembolism (VTE) screening. The preva-
lence of VTE was 34% (105/313). PE without DVT was 4% 
(11/313) and DVT with or without PE was 30% (94/313). 
DVT-CT revealed ICVT in 76 limbs of 73 patients. Of them, 
39 limbs of 37 patients who underwent follow-up DVT-CT 
were enrolled in this study. By retrospective review of pro-
spectively registered medical records, we investigated the 
incidence of resolution and proximal propagation of ICVT 
as well as the incidence of PE.
Regarding treatment, indications of 3 to 6 months oral 
anticoagulation therapy were as follows: 1) concomitant 
PE regardless of symptom, 2) concomitant proximal DVT 
in contralateral limb, 3) previous episode of DVT.
The patients with ICVTs were categorized into two 
groups according to treatment. Seventeen patients with 18 
limbs (group I, oral anticoagulation group) were treated 3 
to 6 months with oral anticoagulation therapy following 
low molecular weight heparin (LMWH) and 20 patients 
with 21 limbs (group II, conservative treatment group) 
were not. Among group II, however, 11 patients received 
short-term (3 to 7 days) LMWH during admission and 15 
patients received antiplatelet therapy for 3 to 6 months. 
Neither anticoagulation nor antiplatelet agent was ad-
ministered for 4 patients.
Sixteen patients had concomitant PE and all were 
asymptomatic. All belonged to group I, except 1 patient 
who discontinued anticoagulation due to hematemesis 
one day after anticoagulation therapy.
CT was performed using a Light Speed 16 CT scanner 
(GE Healthcare, Milwaukee, WI, USA) or Aquilion 64 CT 
scanner (Toshiba Medical Systems Co., Tokyo, Japan). The 
contrast media (Optiray 320, Tyco Healthcare, Mallin-
krodt, Saint Louis, MO, USA) with a volume of 140 mL was 
administered through an antecubital vein using an auto-
mated power injector at a rate of 3 to 4 mL/sec and was fol-
lowed a 30 mL saline chaser with the same infusion rate. 
Individual contrast optimization was achieved using bo-
lus tracking within the main pulmonary artery. CT pulmo-
nary arteriography was obtained during a shallow in-
spiratory breathhold in a craniocaudal direction from the 
aortic arch to the heart base. At 180 seconds after injection 
of the contrast agent, CT venography was performed from 
the heart base down to the feet in the craniocaudal 
direction.
RESULTS
Patient mean age was 68 years (range, 48 to 86 years) and 
95% were female. Two patients had bilateral ICVT and 1 
patient had a contralateral proximal DVT. Sixteen patients 
had a concomitant PE and all were asymptomatic. The risk 
factors for VTE are shown in Table 1. Two patients had a 
previous episode of ICVT of the contralateral limb after Woo-Sung Yun, et al.
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Fig. 1. Computed tomography (CT) of 66-year-old woman who underwent right total knee arthroplasty (TKA). She was treated with oral 
anticoagulation therapy for 3 months due to isolated calf vein thrombosis (ICVT) with pulmonary embolism (PE). (A) CT at 7 days after TKA
revealed PE in right posterior basal segmental artery (arrow) and thrombosis in right muscular calf veins (arrow heads). (B) Follow-up CT 
after 4 months revealed complete resolution of ICVT and PE.
Table 2. Clinical characteristics of isolated calf vein thrombosis
Characteristic
Oral 
anticoagulation 
(n = 18)
Conservative 
treatment 
(n = 21)
Total 
(n = 39)
No. of thrombosed veins
  1 10 (56)   8 (38) 18 (46)
  2   4 (22) 10 (48) 14 (36)
  ≥3   4 (22)   3 (14)   7 (18)
Location
  Crural vein
a)   9 (50)   7 (33) 16 (41)
  Crural vein and   5 (28)   5 (24) 10 (26)
    muscular vein
  Muscular vein
b)   4 (22)   9 (43) 13 (33)
Values are presented as no. of limbs (%).
a)Anterior tibial vein, posterior tibial vein and peroneal vein. 
b)Gastrocnemius vein and soleal vein.
contralateral TKA and 1 patient had undergone cathe-
ter-directed thrombolysis and left iliac vein stenting due to 
May-Thurner syndrome 5 years ago.
Table 2 summarizes the locations of ICVT and the num-
ber of thrombosed veins. Fifty-four percent involved more 
than 1 vein. Among the crural veins, peroneal vein throm-
bosis occurred in 16 limbs as well as the posterior tibial 
vein, but the anterior tibial vein was not involved in any 
case. Isolated muscular calf vein thrombosis (IMCVT) was 
seen in 33% (13/39) of patients. Follow-up DVT-CT re-
vealed complete resolution of ICVT and PE in the oral anti-
coagulation group (Fig. 1). In the conservative treatment 
group, ICVT also disappeared on follow-up DVT-CT and 
there was no newly developed PE (Fig. 2).
DISCUSSION
There were many reports on ICVT, but its clinical im-
plication and treatment remains controversial. Tradition-
ally, main concerns in DVT treatment are the risk of PE and Outcome of isolated calf vein thrombosis
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Fig. 2. Computed tomography (CT) of 67-year-old man who underwent right total knee arthroplasty (TKA). He was treated with low 
molecular weight heparin for 5 days during admission and took antiplatelet agent for 3 months. (A) CT at 7 days after TKA revealed 
thrombosis in right peroneal vein (open arrow), posterior tibial vein (solid arrow), and muscular vein (arrow head). (B) Previous thrombus 
disappeared on follow-up CT after 3 months.
post-thrombotic syndrome.
There were autopsy studies demonstrating that ICVT 
was a source of fatal PE [5,6]. Sevitt and Gallagher [5] per-
formed autopsies in 74 fatal cases of PE and the rate of fatal 
PE from ICVT was 15% (11/74). In another autopsy study 
of 23 patients who died of PE, ICVT was detected in 3 pa-
tients (13%) [6]. Although the reported incidence of PE in 
patients with ICVT range from 7 to 50% [3,7-9], fatal PE 
caused by ICVT is rarely reported in clinical studies. 
However, 20 to 50% of untreated proximal DVT results in 
significant PE and 5% of such PE are fatal [10]. Therefore, 
another issue of ICVT is its propagation to the level of or 
above the popliteal vein.
Based on serial duplex scans of 192 patients with ICVT, 
Lohr et al. [11] reported that 28% had propagation of their 
initial thrombi. Propagation up to the proximal veins oc-
curred in 21 patients (11%). They failed to identify risk fac-
tors of thrombus propagation. In a randomized pro-
spective studyin 51 patients with ICVT diagnosed by con-
trast venography [12], 29% (8/28) of the non-warfarin group 
had recurrences and 18% (5/28) were recurrences with 
proximal extension during the first 3 months. However, 
there were no recurrences in the warfarin group (P ＜ 
0.01). After 1 year, there recurrence rate was 68% in the 
non-warfarin group, while there were no recurrences in 
the warfarin group, except for 1 patient who died of lung 
cancer after 4 months (P ＜  0.02). Lautz et al. [13] reported 
a mean 7.5 months follow-up result of 452 limbs in 406 pa-
tients with IMCVT. VTE event occurred in 18.7% of the 
patients. According to the treatment, the incidence of VTE 
events was significantly lower after therapeutic anti-
coagulation (12% in the anticoagulation group vs. 27% in 
the prophylactic anticoagulation group vs. 30% in the no 
anticoagulation group, P = 0.0003). 
On the contrary, there are some reports that post-
operative ICVT is insignificant. Wang et al. [14] performed 
ascending venography after TKA and identified 51 pa-
tients with ICVT. Symptomatic ICVT was treated with 
heparin or LMWH for 3 to 7 days and asymptomatic pa-
tients received no medication. Follow-up venography was 
performed in 37 patients. It showed no thrombosis except 
in 1 patient who had residual thrombi in the muscular 
branches. In other study [15], a serial follow-up duplex 
scan was performed for 42 patients (50 limbs) with ICVT 
after total hip arthroplasty or TKA. Its proximal prop-
agation rate was not influenced by anticoagulation (23% in 
treated limbs vs. 8% in untreated limbs, P = 0.43). The au-
thors suggested that postoperative calf vein thrombosis 
need not be routinely treated and serial venous duplex 
scanning is useful to identify thrombotic propagation re-
quiring anticoagulation.
Masuda et al. [16] reported that proximal propagation 
of ICVT developed in 4% of the cases within 2 weeks of di-
agnosis and clinically overt PE did not occur regardless of Woo-Sung Yun, et al.
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whether anticoagulation therapy was received or not. 
Meissner et al. [17] monitored 29 limbs with ICVT with du-
plex scan. Median propagation time of ICVT was 11 days. 
MacDonald et al. [18] performed serial duplex scansfor 
135 limbs with IMCVT that were not treated with anti-
coagulation therapy. Only 3% of the patients extended 
their thrombi to the level of the popliteal vein and all oc-
curred within 2 weeks.
Considering most thrombus propagations occur in the 
early period, it is reasonable that short-term anticoagula-
tion may be adopted for patients with ICVT. There was a 
report that short-term anticoagulation in IMCVT is useful 
to prevent VTE complications [19], but it was not proven in 
a prospective randomized study [20]. The authors com-
pared treatment outcomes between a short-term anti-
coagulation group (treated with LMWH for 10 days) and a 
compression group. There was no difference in the throm-
bus propagation rate (3.7% in LMWH group vs. 3.8% in 
compression group) and there was no clinical PE and no 
death.
Another issue in ICVT is post-thrombotic syndrome. In 
several studies, long-term symptoms and significant he-
modynamic changes occur after ICVT [21-23]. Browse et 
al. [21] reported a 20% incidence of moderate to severe 
postphlebitic symptoms and signs 5 to 10 years after 
symptomatic ICVT. Meissner et al. [22] reported that 23% 
of patients with ICVT showed persistent symptoms and 
the development of valvular incompetence at 1 year, al-
though recanalization proceeded rapidly. In a population- 
based study [23], the cumulative incidence of post-throm-
botic syndrome after ICVT was 10.2%, 22%, and 29.8% at 2 
years, 10 years, and 20 years respectively.
We preferred 3-month oral anticoagulation therapy for 
patients with ICVT if a patient had a concomitant PE at ini-
tial diagnosis. On follow-up DVT-CT 3 to 6 months after 
the first diagnosis of ICVT, thrombus propagation was not 
detected and all ICVTs resolved regardless of treatment. 
And, there was no newly developed PE in the conservative 
treatment group. This result suggests that 3-month oral 
anticoagulation therapy for ICVT patients without PE af-
ter TKA may not be necessary concerning the risk of prox-
imal thrombus propagation and development of PE. It is 
assumed that most postoperative ICVT resolve sponta-
neously when the postoperative period passes and the pa-
tients can ambulate because TKA is a transient risk factor 
for VTE.
The limitation of this study is that it is a retrospective 
design with no randomization. Further, long-term follow- 
up is necessary to evaluate disease recurrence and post- 
thrombotic syndrome. Indeed, to establish a consensus 
guideline for ICVT treatment, a large-scale prospective 
randomized study is necessary.
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